What is the NOAEL for 4-Chloro-3,5-dimethylphenol?
4-Chloro-3,5-dimethylphenol has 59 NOAEL studies in the database. The lowest reported value is 0 % via Dermal in Human. Source: NTP ICE skin sensitization.
Also known as: 4-Chloro-3,5-xylenol, Chloroxylenol, BRN 1862539, Caswell No. 218, 2-Chloro-m-xylenol (+15 more)
CAS 88-04-0
4-Chloro-3,5-dimethylphenol (CAS 88-04-0) is a chemical substance. Key regulatory status: REACH registered, 12 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS, ECHA REACH.
CAS, identifiers, formula, and alternate names for the matched substance record.
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| active_ingredient; Pesticides | State of California | State of California |
| active_ingredient; Pesticides | State of California | State of California |
| active_ingredient; Pesticides | State of California | State of California |
| active_ingredient; Pesticides | State of California | State of California |
| active_ingredient; Pesticides | State of California | State of California |
| pharmaceutical | US International Trade Commission | CPCat |
| CEDI | FDA | United States Food and Drug Administration (FDA) |
| Indirect additives food contact (10/2018) | FDA | United States Food and Drug Administration (FDA) |
| active_ingredient; Europe; Pesticides | Commission of the European Communities | CPCat |
| Europe; Personal care | European Commission | CosIng |
| inert_ingredient; non_food_use; Pesticides | EPA | CPCat |
| IFRA Transparency | IFRA | IFRA |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 26.58 | uM | AC50 | - | - | NTP ICE endocrine |
| 19.56 | uM | ACC | - | - | NTP ICE endocrine |
| 30 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP ICE skin sensitization |
| 4 | % | Concentration, one positive response | Dermal | Human | NTP ICE skin sensitization |
| 1 | unitless | EPA Classification | Ocular | Rabbit | NTP ICE eye irritation |
| 3 | unitless | EPA classification | Dermal | Rat | NTP ICE acute dermal |
| =3 | Unitless | EPA classification | oral | Rat | NTP ICE acute oral |
| 4 | unitless | EPA classification | Dermal | Rat | NTP ICE acute dermal |
| 4 | unitless | EPA classification | Dermal | Rabbit | NTP ICE skin irritation |
| 0F32U78V2Q | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 4 | unitless | GHS Classification | Inhalation | - | NTP ICE acute inhalation |
| 5 | unitless | GHS Classification | Inhalation | - | NTP ICE acute inhalation |
| 5 | unitless | GHS classification | Dermal | Rat | NTP ICE acute dermal |
| =5 | Unitless | GHS classification | oral | Rat | NTP ICE acute oral |
| 0 | % | Incidence of positive responses | Dermal | Human | NTP ICE skin sensitization |
| 3.333 | % | Incidence of positive responses | Dermal | Human | NTP ICE skin sensitization |
| 3488 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP ICE skin sensitization |
| 6975 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP ICE skin sensitization |
| 1.395e+4 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP ICE skin sensitization |
| 2.250e+4 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP ICE skin sensitization |
| 3.375e+4 | ug/cm2 | Induction dose per skin area, 5% incidence of positive responses | Dermal | Human | NTP ICE skin sensitization |
| 4500 | ug/cm2 | Induction dose per skin area, one positive response | Dermal | Human | NTP ICE skin sensitization |
| 2.26 | mg/L | LC50 | Inhalation | - | NTP ICE acute inhalation |
| 6.29 | mg/L | LC50 | Inhalation | - | NTP ICE acute inhalation |
| >2000 | mg/kg | LD50 | Dermal | Rat | NTP ICE acute dermal |
| =3830 | mg/kg bw | LD50 | oral | Rat | NTP ICE acute oral |
| >5050 | mg/kg | LD50 | Dermal | Rat | NTP ICE acute dermal |
| =213 | mg/kg bw/day | LEL | dermal | Mouse | ToxValDB ToxRefDB |
| =213 | mg/kg bw/day | LEL | dermal | mouse (cd1; Crl:CD-1(ICR)BR) | EPA ToxRefDB v3 |
| =284 | mg/kg bw/day | LEL | dermal | Mouse | ToxValDB ToxRefDB |
| =284 | mg/kg bw/day | LEL | dermal | mouse (cd1; Crl:CD-1(ICR)BR) | EPA ToxRefDB v3 |
| =300 | mg/kg bw/day | LEL | oral | Rat | ToxValDB ToxRefDB |
| =300 | mg/kg bw/day | LEL | oral | rat (sprague dawley; Sprague Dawley (CD)) | EPA ToxRefDB v3 |
| =500 | mg/kg bw/day | LEL | oral | Rat | ToxValDB ToxRefDB |
| =500 | mg/kg bw/day | LEL | oral | rat (sprague dawley; Sprague Dawley (CD)) | EPA ToxRefDB v3 |
| >1000 | mg/kg bw/day | LEL | oral | Rat | ToxValDB ToxRefDB |
| =1250 | mg/kg bw/day | LEL | oral | Rat | ToxValDB ToxRefDB |
| =1250 | mg/kg bw/day | LEL | oral | rat (sprague dawley; Sprague Dawley) | EPA ToxRefDB v3 |
| =7900 | mg/m3 | LEL | inhalation | Rat | ECHA |
| =1000 | mg/kg bw/day | LOAEL | oral | rat (sprague dawley; Sprague Dawley (CD)) | EPA ToxRefDB v3 |
| =2500 | mg/kg bw/day | LOAEL | oral | Rat | ToxValDB ToxRefDB |
| =2500 | mg/kg bw/day | LOAEL | oral | rat (sprague dawley; Sprague Dawley) | EPA ToxRefDB v3 |
| =0.5 | mL/kg-day | LOEL | oral | Dog | ToxValDB ECOTOX |
| =5 | mL/kg-day | LOEL | oral | Dog | ToxValDB ECOTOX |
| =25 | % | LOEL | dermal | Mouse | ToxValDB ECOTOX |
| 0 | unitless | Model Score | - | - | NTP ICE endocrine |
| 0.0439 | unitless | Model Score | - | - | NTP ICE endocrine |
| >0 | mg/kg bw/day | NEL | dermal | mouse (cd1; Crl:CD-1(ICR)BR) | EPA ToxRefDB v3 |
| =25 | mg/kg bw/day | NEL | oral | Rat | ToxValDB ToxRefDB |
| =25 | mg/kg bw/day | NEL | oral | rat (sprague dawley; Sprague Dawley) | EPA ToxRefDB v3 |
Showing 50 of 59 studies
Registration status from the ECHA REACH registered substances database.
| Status | Name | EC Number | Link |
|---|---|---|---|
| Registered | 4-chloro-3,5-xylenol | 201-793-8 | ECHA overview → |
Australian industrial chemicals inventory status and applicable conditions.
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
4-Chloro-3,5-dimethylphenol has 59 NOAEL studies in the database. The lowest reported value is 0 % via Dermal in Human. Source: NTP ICE skin sensitization.
4-Chloro-3,5-dimethylphenol appears on 8 regulatory/inventory lists including active_ingredient; Pesticides, pharmaceutical, CEDI, and 5 more. Source: EPA CPDat.
Yes, 4-Chloro-3,5-dimethylphenol is also indexed as a cosmetic ingredient under the name Chloroxylenol (PCMX). View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, ECHA REACH, CosIng / Ingredients DB, ChEMBL / DailyMed. All data traces to primary regulatory sources and is updated from official government databases.
4-Chloro-3,5-dimethylphenol also appears in cosmetics, pharmaceutical databases.